Inovio Pharmaceuticals (INO)
NASDAQ:INO

Inovio Pharmaceuticals Stock Price & Analysis

5,464 Followers

INO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.38 - $6.74
Previous Close$1.92
Volume2.87M
Average Volume (3M)5.86M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$281.88M
Total Debt (Recent Filing)$32.43M
Price to Earnings (P/E)-1.3
Beta1.45
Next EarningsMar 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.47
Shares Outstanding249,489,264
R-Squared0.04
Standard Deviation0.26
10 Day Avg. Volume5,366,562
30 Day Avg. Volume5,860,878
Price to Book (P/B)2.00
Price to Sales (P/S)43.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside31.23% Upside
Rating ConsensusHold
Alpha0.00713
Number of Analyst Covering4


Financials


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

INO FAQ

What was Inovio Pharmaceuticals’s price range in the past 12 months?
Inovio Pharmaceuticals lowest stock price was $1.38 and its highest was $6.74 in the past 12 months.
    What is Inovio Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Inovio Pharmaceuticals’s upcoming earnings report date?
    Inovio Pharmaceuticals’s upcoming earnings report date is Mar 15, 2023 which is in 103 days.
      How were Inovio Pharmaceuticals’s earnings last quarter?
      Inovio Pharmaceuticals released its earnings results on Nov 08, 2022. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.291 by $0.141.
        Is Inovio Pharmaceuticals overvalued?
        According to Wall Street analysts Inovio Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Inovio Pharmaceuticals pay dividends?
          Inovio Pharmaceuticals does not currently pay dividends.
          What is Inovio Pharmaceuticals’s EPS estimate?
          Inovio Pharmaceuticals’s EPS estimate is -$0.17.
            How many shares outstanding does Inovio Pharmaceuticals have?
            Inovio Pharmaceuticals has 249,489,260 shares outstanding.
              What happened to Inovio Pharmaceuticals’s price movement after its last earnings report?
              Inovio Pharmaceuticals reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.291. Following the earnings report the stock price went up 1.869%.
                Which hedge fund is a major shareholder of Inovio Pharmaceuticals?
                Among the largest hedge funds holding Inovio Pharmaceuticals’s share is Caxton Associates LP. It holds Inovio Pharmaceuticals’s shares valued at 226K.

                  ---

                  Inovio Pharmaceuticals Stock Smart Score

                  The Inovio Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Inovio Pharmaceuticals

                  Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Coherus Biosciences
                  Caribou Biosciences
                  BioAtla
                  Zymeworks
                  AKOUOS

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis